AU2010229336A1 - Medication disposal system - Google Patents
Medication disposal system Download PDFInfo
- Publication number
- AU2010229336A1 AU2010229336A1 AU2010229336A AU2010229336A AU2010229336A1 AU 2010229336 A1 AU2010229336 A1 AU 2010229336A1 AU 2010229336 A AU2010229336 A AU 2010229336A AU 2010229336 A AU2010229336 A AU 2010229336A AU 2010229336 A1 AU2010229336 A1 AU 2010229336A1
- Authority
- AU
- Australia
- Prior art keywords
- medication
- container
- disposal system
- activated carbon
- binding agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title claims abstract description 139
- 229940079593 drug Drugs 0.000 title claims abstract description 138
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 145
- 238000002483 medication Methods 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 20
- 230000007613 environmental effect Effects 0.000 claims abstract description 13
- 239000011230 binding agent Substances 0.000 claims description 41
- 239000000126 substance Substances 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000003349 gelling agent Substances 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 15
- 239000005557 antagonist Substances 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- 239000002085 irritant Substances 0.000 claims description 12
- 231100000021 irritant Toxicity 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000011109 contamination Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 239000007800 oxidant agent Substances 0.000 claims description 10
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 8
- 230000001590 oxidative effect Effects 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 230000009849 deactivation Effects 0.000 claims description 5
- 239000002699 waste material Substances 0.000 claims description 5
- 239000011888 foil Substances 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 11
- 238000007789 sealing Methods 0.000 claims 6
- 239000003638 chemical reducing agent Substances 0.000 claims 4
- 201000009032 substance abuse Diseases 0.000 claims 4
- 231100000736 substance abuse Toxicity 0.000 claims 4
- 208000011117 substance-related disease Diseases 0.000 claims 4
- 239000002184 metal Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 239000007833 carbon precursor Substances 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000002906 medical waste Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 31
- 229960004207 fentanyl citrate Drugs 0.000 description 11
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 229960001259 diclofenac Drugs 0.000 description 8
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 8
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 8
- 238000002798 spectrophotometry method Methods 0.000 description 8
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 229960002428 fentanyl Drugs 0.000 description 7
- 229960004194 lidocaine Drugs 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229960004515 diclofenac potassium Drugs 0.000 description 3
- KXZOIWWTXOCYKR-UHFFFAOYSA-M diclofenac potassium Chemical compound [K+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KXZOIWWTXOCYKR-UHFFFAOYSA-M 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000010813 municipal solid waste Substances 0.000 description 3
- 229940005483 opioid analgesics Drugs 0.000 description 3
- -1 oxidizing Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 239000000599 controlled substance Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003673 groundwater Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 2
- 229960004127 naloxone Drugs 0.000 description 2
- 239000004081 narcotic agent Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000284152 Carapichea ipecacuanha Species 0.000 description 1
- 239000009471 Ipecac Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 229940123257 Opioid receptor antagonist Drugs 0.000 description 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229940099191 duragesic Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical class Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940029408 ipecac Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 description 1
- 229960003086 naltrexone Drugs 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229940105606 oxycontin Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
- A62D3/33—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by chemical fixing the harmful substance, e.g. by chelation or complexation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J15/00—Chemical processes in general for reacting gaseous media with non-particulate solids, e.g. sheet material; Apparatus specially adapted therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
- B09B3/0075—Disposal of medical waste
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/16—End- or aperture-closing arrangements or devices
- B65D33/25—Riveting; Dovetailing; Screwing; using press buttons or slide fasteners
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B2101/00—Type of solid waste
- B09B2101/65—Medical waste
- B09B2101/68—Transdermal patches
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W30/00—Technologies for solid waste management
- Y02W30/20—Waste processing or separation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Environmental & Geological Engineering (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Processing Of Solid Wastes (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Bag Frames (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Basic Packing Technique (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/412,144 US8535711B2 (en) | 2004-01-23 | 2009-03-26 | Medication disposal system |
| US12/412,144 | 2009-03-26 | ||
| PCT/US2010/000552 WO2010110837A1 (fr) | 2009-03-26 | 2010-02-25 | Système d'élimination des médicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2010229336A1 true AU2010229336A1 (en) | 2011-09-08 |
Family
ID=42781317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010229336A Abandoned AU2010229336A1 (en) | 2009-03-26 | 2010-02-25 | Medication disposal system |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8535711B2 (fr) |
| EP (1) | EP2421639B1 (fr) |
| JP (2) | JP5689110B2 (fr) |
| KR (2) | KR101386047B1 (fr) |
| CN (1) | CN102341164A (fr) |
| AU (1) | AU2010229336A1 (fr) |
| BR (1) | BRPI1006922A2 (fr) |
| CA (1) | CA2754215C (fr) |
| EA (1) | EA201190187A1 (fr) |
| IL (1) | IL213942A0 (fr) |
| MX (1) | MX2011007888A (fr) |
| SG (1) | SG174894A1 (fr) |
| WO (1) | WO2010110837A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
| US8490795B2 (en) | 2010-02-01 | 2013-07-23 | Mallinckrodt Llc | Container and method for facilitating disposal of unused pharmaceutical product |
| US9046403B2 (en) * | 2010-02-01 | 2015-06-02 | Mallinckrodt Llc | Systems and methods for managing use of a medicament |
| US20110272428A1 (en) * | 2010-05-10 | 2011-11-10 | Mallinckrodt Inc. | Method and apparatus for disposal of a pharmaceutical product blister card |
| WO2012017228A1 (fr) * | 2010-08-02 | 2012-02-09 | Archimedes Development Limited | Contenant de distribution de médicament |
| GB2487951A (en) * | 2011-02-10 | 2012-08-15 | Safer Options Ltd | A container for the disposal of drugs having a sachet of super absorbent |
| KR20140067042A (ko) * | 2011-09-30 | 2014-06-03 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 일반 약물 처리 시스템 |
| CA2846956C (fr) | 2011-09-30 | 2017-12-12 | Teikoku Pharma Usa, Inc. | Systeme d'elimination de timbres cutanes |
| US9035121B1 (en) * | 2012-03-23 | 2015-05-19 | Scott S. Goodsell | Method and apparatus for home medication disposal |
| US20140183070A1 (en) * | 2012-12-28 | 2014-07-03 | QRxPharma Ltd. | Device for Disposing Medicament Products |
| CN104670672A (zh) * | 2013-11-29 | 2015-06-03 | 哈尔滨智木科技有限公司 | 液体过保质期提示装置 |
| US20150231673A1 (en) * | 2014-02-14 | 2015-08-20 | Milton Dallas | Medication Disposal System |
| US10137325B2 (en) * | 2014-03-24 | 2018-11-27 | Shantha Sarangapani | System and method for deactivation and disposal of a pharmaceutical dosage form |
| GB201405602D0 (en) * | 2014-03-28 | 2014-05-14 | Best Andrew | Controlled drug deconstruction |
| US20160361667A1 (en) * | 2015-06-12 | 2016-12-15 | Insys Development Company, Inc. | Disposal System for Unused Pharmaceuticals |
| CA2972220C (fr) | 2016-06-29 | 2023-01-24 | Disposerx, Inc. | Elimination de medicaments |
| CN106378350A (zh) * | 2016-10-31 | 2017-02-08 | 包志祥 | 一种试剂盒用废料处理装置 |
| US10898934B2 (en) | 2017-01-30 | 2021-01-26 | Kirti H. Valia | Drug disposal devices and methods of use |
| JP7183199B2 (ja) * | 2017-06-30 | 2022-12-05 | ストライカー・コーポレイション | 医薬廃棄物の受入と廃棄のための廃棄物処理システム及び廃棄物レシーバ |
| US11446531B2 (en) | 2017-10-27 | 2022-09-20 | NarcX | Medication disposal solution |
| US11389844B2 (en) * | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
| US10597206B2 (en) * | 2018-06-15 | 2020-03-24 | Kenneth Corey | Medicine container cover |
| USD968640S1 (en) | 2018-12-27 | 2022-11-01 | Stryker Corporation | Pharmaceutical waste disposal assembly |
| WO2021030223A1 (fr) | 2019-08-09 | 2021-02-18 | Nopioid, Llc | Procédé et compositions pour rendre les opioïdes sans danger |
| US10653911B1 (en) | 2019-08-14 | 2020-05-19 | Phong Duy Bui | System for liquid narcotic medication validation and deactivation |
| USD989303S1 (en) | 2019-12-12 | 2023-06-13 | Stryker Corporation | Pharmaceutical waste disposal assembly |
| CN113102473B (zh) * | 2021-05-07 | 2022-07-05 | 泉州师范学院 | 一种过期药物无害化处理方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
| JPS61171537A (ja) * | 1985-01-24 | 1986-08-02 | Shigekazu Nakano | 臭気成分除去用ゲル状吸着剤 |
| US4909256A (en) | 1985-02-11 | 1990-03-20 | The United States Of America, As Represented By The Secretary Of The Army | Transdermal vapor collection method and apparatus |
| US4853266A (en) * | 1986-05-16 | 1989-08-01 | Multiform Desiccants, Inc. | Liquid absorbing and immobilizing packet containing a material for treating the absorbed liquid |
| US5899856A (en) | 1988-09-08 | 1999-05-04 | Sudormed, Inc. | Dermal patch detecting long-term alcohol consumption and method of use |
| JPH0285182A (ja) * | 1988-09-09 | 1990-03-26 | Hagiwara Kogyo Kk | 脱臭及び、鮮度保持袋 |
| US5236714A (en) | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
| US5022553A (en) * | 1990-05-29 | 1991-06-11 | Pontius Jeffrey S | Temporary diaper storage container |
| US5149538A (en) | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
| US5451444A (en) * | 1993-01-29 | 1995-09-19 | Deliso; Evelyn M. | Carbon-coated inorganic substrates |
| JP2950520B2 (ja) | 1993-04-02 | 1999-09-20 | アンティキャンサー インコーポレーテド | 毛胞に有益な配合物を送達する方法 |
| US5396901A (en) | 1994-01-11 | 1995-03-14 | Phillips; Michael | Transdermal dosimeter device |
| US6279736B1 (en) | 1995-04-19 | 2001-08-28 | Capitol Specialty Plastics, Inc. | Barrier pack having an absorbing agent applied to the interior of the pack |
| JPH0975723A (ja) * | 1995-07-20 | 1997-03-25 | Koki Bussan Kk | 有害物質の吸着除去剤 |
| US5804215A (en) * | 1997-03-21 | 1998-09-08 | L. Perrigo Company | Transdermal patch disposal system and method |
| US7011843B2 (en) | 1997-10-01 | 2006-03-14 | Lts Lohmann-Therapie Systeme Ag | Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system |
| JP5367200B2 (ja) * | 1998-11-16 | 2013-12-11 | ザ プロクター アンド ギャンブル カンパニー | 臭気中和化および液体吸収性廃棄物袋 |
| JP2000206111A (ja) * | 1999-01-20 | 2000-07-28 | Sekisui Chem Co Ltd | 真空採血管用包装容器 |
| US6660901B2 (en) | 1999-09-24 | 2003-12-09 | Glenda Church | Charcoal skin patch |
| US6261595B1 (en) | 2000-02-29 | 2001-07-17 | Zars, Inc. | Transdermal drug patch with attached pocket for controlled heating device |
| US6475513B1 (en) * | 2001-04-09 | 2002-11-05 | Kiyoshi Yamada | Skin-care pouch |
| DE60235555D1 (de) * | 2001-04-23 | 2010-04-15 | Euro Celtique Sa | Entsorgungssystem für transdermale dosierformen |
| PT2062573E (pt) | 2001-05-01 | 2012-01-11 | Euro Celtique Sa | Sistemas transdérmicos que contêm opióides que resistem a violação |
| US6797857B2 (en) * | 2001-05-24 | 2004-09-28 | Deroyal Industries | Solidifier for a liquid |
| US20030078552A1 (en) * | 2001-06-01 | 2003-04-24 | The Procter & Gamble Company | Odor-controlling disposal container |
| US7332182B2 (en) | 2001-08-06 | 2008-02-19 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant |
| JP3097492U (ja) * | 2002-02-04 | 2004-01-29 | 楠野 弦 | 開口部分に切り込み溝を有する物品収納袋 |
| US20060110080A1 (en) | 2002-02-27 | 2006-05-25 | Thomas Toby R | Packages and structures with selective dosing of active agent |
| ES2361068T3 (es) | 2002-04-23 | 2011-06-13 | Durect Corporation | Sistemas analgésicos transdérmicos con potencial de abuso reducido. |
| CN101455649B (zh) | 2002-06-10 | 2014-02-26 | 欧洲凯尔特公司 | 防止所含活性剂被误用的经皮给药器的处置系统 |
| US8524272B2 (en) | 2003-08-15 | 2013-09-03 | Mylan Technologies, Inc. | Transdermal patch incorporating active agent migration barrier layer |
| US7275645B2 (en) | 2003-09-19 | 2007-10-02 | Vesta Medical, Llc | Handheld medical waste sorting device |
| US7867511B2 (en) * | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
| ITMI20041332A1 (it) * | 2004-07-01 | 2004-10-01 | N G G Medical S P A | Struttura di contenitore rigido monouso particolarmente per la raccolta dei liquidi sanitari contaminati per il loro smaltimento in forma semi-solida |
| JP4994138B2 (ja) * | 2007-07-18 | 2012-08-08 | 株式会社生産日本社 | 袋開封用テープ及び包装袋 |
| US7918776B2 (en) | 2007-11-19 | 2011-04-05 | Sherry Day | Composition for disposing of unused medicines |
-
2009
- 2009-03-26 US US12/412,144 patent/US8535711B2/en active Active
-
2010
- 2010-02-25 CA CA2754215A patent/CA2754215C/fr active Active
- 2010-02-25 AU AU2010229336A patent/AU2010229336A1/en not_active Abandoned
- 2010-02-25 CN CN2010800104513A patent/CN102341164A/zh active Pending
- 2010-02-25 KR KR1020137019375A patent/KR101386047B1/ko active IP Right Grant
- 2010-02-25 SG SG2011068483A patent/SG174894A1/en unknown
- 2010-02-25 BR BRPI1006922A patent/BRPI1006922A2/pt not_active IP Right Cessation
- 2010-02-25 EP EP10756448.6A patent/EP2421639B1/fr active Active
- 2010-02-25 KR KR1020117016991A patent/KR20110122105A/ko active Application Filing
- 2010-02-25 MX MX2011007888A patent/MX2011007888A/es active IP Right Grant
- 2010-02-25 JP JP2012501988A patent/JP5689110B2/ja active Active
- 2010-02-25 EA EA201190187A patent/EA201190187A1/ru unknown
- 2010-02-25 WO PCT/US2010/000552 patent/WO2010110837A1/fr active Application Filing
-
2011
- 2011-07-05 IL IL213942A patent/IL213942A0/en unknown
-
2014
- 2014-07-17 JP JP2014147069A patent/JP6110820B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014237001A (ja) | 2014-12-18 |
| JP5689110B2 (ja) | 2015-03-25 |
| CA2754215C (fr) | 2015-08-11 |
| WO2010110837A1 (fr) | 2010-09-30 |
| SG174894A1 (en) | 2011-11-28 |
| EP2421639A1 (fr) | 2012-02-29 |
| JP2012521263A (ja) | 2012-09-13 |
| CA2754215A1 (fr) | 2010-09-30 |
| MX2011007888A (es) | 2011-11-04 |
| JP6110820B2 (ja) | 2017-04-05 |
| EP2421639A4 (fr) | 2014-07-09 |
| CN102341164A (zh) | 2012-02-01 |
| BRPI1006922A2 (pt) | 2016-02-16 |
| US20090180936A1 (en) | 2009-07-16 |
| KR20110122105A (ko) | 2011-11-09 |
| KR20130087631A (ko) | 2013-08-06 |
| US8535711B2 (en) | 2013-09-17 |
| EA201190187A1 (ru) | 2012-04-30 |
| EP2421639B1 (fr) | 2020-01-15 |
| IL213942A0 (en) | 2011-07-31 |
| KR101386047B1 (ko) | 2014-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2754215C (fr) | Systeme d'elimination des medicaments | |
| US11305144B2 (en) | Abuse potential reduction in abusable substance dosage form | |
| EP2760412B1 (fr) | Système d'application générale pour la mise au rebut de médicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |